Investment bankers embrace ‘intense’ pitching as groups in defence, tech and wider economy prepare to go public ...

Fast-forward to 2026, and we’ve already seen a handful of U.S. biotechs line up to squeeze through a gradually reopening IPO ...

Shadowfax Technologies IPO saw strong demand with a subscription status of 2.72x. The allotment date was January 23, and ...

The valuation increased threefold since its last valuation in 2023.

The debut signals a shift for digital asset infrastructure, with Goldman Sachs and Citigroup leading the underwriting ...

By Echo Wang and Prakhar Srivastava Jan 22 (Reuters) - Elon Musk's space startup SpaceX is lining up four Wall Street banks ...

Ethos was backed by a who's who of VCs and celebs through 2021. It is currently profitable, it says.

VanEck analyst calls it a "superior asset" within its valuation range.

By Jan Lopatka and Jason Hovet PRAGUE, Jan 20 (Reuters) - Prague-based Czechoslovak Group (CSG) will float up to a 15.2% ...

The four Wall Street firms are currently selling existing shares valuing the company at $800 billion, according to reports.

SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...

Armored vehicle and munitions maker Czechoslovak Group is set to start trading in Amsterdam on Friday morning, after the firm ...